PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 84 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 4.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,868,000 | -56.6% | 444,687 | -2.5% | 0.05% | -53.3% |
| Q1 2017 | $4,305,000 | +80.9% | 456,033 | +65.6% | 0.10% | +23.5% |
| Q4 2016 | $2,380,000 | +8.9% | 275,415 | -27.9% | 0.08% | +23.2% |
| Q3 2015 | $2,185,000 | -74.8% | 382,027 | -67.2% | 0.07% | -70.6% |
| Q2 2015 | $8,681,000 | +139.9% | 1,163,608 | +92.3% | 0.24% | +155.4% |
| Q1 2015 | $3,618,000 | -56.7% | 605,044 | -45.2% | 0.09% | -50.0% |
| Q4 2014 | $8,351,000 | +1534.2% | 1,103,848 | +1035.0% | 0.18% | +1433.3% |
| Q3 2014 | $511,000 | +23.4% | 97,257 | -4.0% | 0.01% | 0.0% |
| Q1 2014 | $414,000 | -35.6% | 101,275 | -20.8% | 0.01% | -14.3% |
| Q3 2013 | $643,000 | – | 127,856 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |